{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:33:10Z","timestamp":1790375590628,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.humpath.2018.04.007","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T20:46:12Z","timestamp":1524429972000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["IL-13 is produced by tumor cells in breast implant\u2013associated anaplastic large cell lymphoma: implications for pathogenesis"],"prefix":"10.1016","volume":"78","author":[{"given":"Marshall E.","family":"Kadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley A.","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William P.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E.","family":"Bacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao C.S.","family":"Goes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.04.007_bb0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/modpathol.3801024","article-title":"Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder","volume":"21","author":"Roden","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jamaoncol.2017.4510","article-title":"Breast implants and the risk of anaplastic large-cell lymphoma in the breast","volume":"4","author":"de Boer","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","article-title":"Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients","volume":"32","author":"Miranda","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0020","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/1078-0432.CCR-12-0101","article-title":"Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma","volume":"18","author":"Lechner","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.04.007_bb0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/annonc\/mdv575","article-title":"Breast implant associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes","volume":"27","author":"Laurent","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/PRS.0000000000002010","article-title":"Bacterial biofilm infection detected in breast implant associated anaplastic large cell lymphoma","volume":"137","author":"Hu","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.humpath.2018.04.007_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","article-title":"Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma","volume":"34","author":"Clemens","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/asj\/sjw023","article-title":"Biomarkers provide clues to early events in the pathogenesis of breast implant-associated anaplastic large cell lymphoma","volume":"36","author":"Kadin","year":"2016","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.humpath.2018.04.007_bb0045","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/jid.2011.351","article-title":"High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides","volume":"132","author":"Kadin","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0050","doi-asserted-by":"crossref","first-page":"e53767","DOI":"10.1371\/journal.pone.0053767","article-title":"T(8;9)(p22;p24)\/PCM1-JAK2 activates SOCS2 and SOCS3 via STAT5","volume":"8","author":"Ehrentraut","year":"2013","journal-title":"PLoS One"},{"issue":"23","key":"10.1016\/j.humpath.2018.04.007_bb0055","doi-asserted-by":"crossref","first-page":"34201","DOI":"10.18632\/oncotarget.9077","article-title":"Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma","volume":"7","author":"Ehrentraut","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2018.04.007_bb0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cyto.2008.07.014","article-title":"Cytokines as a key component of cancer-related inflammation","volume":"43","author":"Germano","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.humpath.2018.04.007_bb0065","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.04.007_bb0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0075","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/362248a0","article-title":"Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses","volume":"362","author":"Minty","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2018.04.007_bb0080","first-page":"000108","article-title":"Investigation of atopy in primary cutaneous CD30+ T-cell lymphoproliferative disorders","volume":"2","author":"Vonderheid","year":"2017","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1182\/blood-2010-05-285908","article-title":"A novel role for IL-22R1 as a driver of inflammation","volume":"117","author":"Savan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.04.007_bb0090","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1158\/1078-0432.CCR-10-2660","article-title":"Programmed death ligand 1 is expressed by non-Hodgkin lymphomas and inhibits the activity of tumor-associated T cells","volume":"17","author":"Andorsky","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2018.04.007_bb0095","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood.V68.5.1042.1042","article-title":"Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy","volume":"68","author":"Kadin","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.04.007_bb0100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3324\/haematol.2009.015024","article-title":"Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases","volume":"95","author":"Lamant","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2018.04.007_bb0105","first-page":"978","article-title":"Anaplastic lymphoma kinase expression as a marker of malignancy. Application to a case of anaplastic large cell lymphoma with huge granulomatous reaction","volume":"85","author":"Piccaluga","year":"2000","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2018.04.007_bb0110","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1046\/j.1365-2141.1998.01097.x","article-title":"Detection of the t(2;5)\u2013associated NPM\/ALK fusion cDNA in peripheral blood cells of healthy individuals","volume":"103","author":"Trumper","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0115","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2018.04.007_bb0120","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1158\/0008-5472.CAN-03-3764","article-title":"Soluble interleukin-13Ralpha2 decoy receptor inhibits Hodgkin's lymphoma growth in vitro and in vivo","volume":"64","author":"Trieu","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.04.007_bb0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.pas.0000179123.66748.c2","article-title":"ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases","volume":"30","author":"Vassallo","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2018.04.007_bb0130","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1073\/pnas.90.8.3730","article-title":"Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells","volume":"90","author":"Punnonen","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2018.04.007_bb0135","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2018.04.007_bb0140","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.immuni.2016.06.009","article-title":"Interleukin-13 activates distinct cellular pathways leading to Ductular reaction, steatosis, and fibrosis","volume":"45","author":"Gieseck","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.humpath.2018.04.007_bb0145","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2011.01024.x","article-title":"Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases","volume":"242","author":"Burton","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.humpath.2018.04.007_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.imlet.2011.08.004","article-title":"Soluble IgE receptors--elements of the IgE network","volume":"141","author":"Platzer","year":"2011","journal-title":"Immunol Lett"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718301278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T20:27:18Z","timestamp":1571257638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718301278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"alternative-id":["S0046817718301278"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.04.007","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-13 is produced by tumor cells in breast implant\u2013associated anaplastic large cell lymphoma: implications for pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}